This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: PNB-0408
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. It is considered one of the most potent cognitive enhancers ever tested in animal models — reportedly 7 orders of magnitude more potent than BDNF at improving cognitive performance in rodent Alzheimer's models.
Dihexa binds to the hepatocyte growth factor (HGF) receptor c-Met and potentiates HGF signaling. This drives synaptogenesis — the formation of new synaptic connections — in the hippocampus and prefrontal cortex. HGF/c-Met signaling promotes dendritic spine density, axonal sprouting, and synaptic strengthening through downstream PI3K/Akt and MAPK/ERK activation. Unlike BDNF, which acts on TrkB receptors, Dihexa's HGF mechanism represents a completely distinct pathway for enhancing synaptic connectivity.
Dihexa binds to the hepatocyte growth factor (HGF) receptor c-Met and potentiates HGF signaling. This drives synaptogenesis — the formation of new synaptic connections — in the hippocampus and prefrontal cortex. HGF/c-Met signaling promotes dendritic spine density, axonal sprouting, and synaptic strengthening through downstream PI3K/Akt and MAPK/ERK activation. Unlike BDNF, which acts on TrkB receptors, Dihexa's HGF mechanism represents a completely distinct pathway for enhancing synaptic connectivity.
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. It is considered one of the most potent cognitive enhancers ever tested in animal models — reportedly 7 orders of magnitude more potent than BDNF at improving cognitive performance in rodent Alzheimer's models. Exclusively used by the research and biohacking community with no human clinical trial data available.
IUPAC Name
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
CAS Number
1191170-93-0
Molecular Formula
C24H38N4O4
Molecular Mass
450.58 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Neurodegenerative diseases with active degeneration (unknown interaction). Pregnancy or breastfeeding. History of seizures. Concurrent use of other potent nootropics without titration.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$44.99
up to $49.99
$4.9990
2
2
vial
| Vendor | Product | Form | Qty | Price | $/mg | Coupon | |
|---|---|---|---|---|---|---|---|
![]() |
Dihexa 5mg | vial | 1 vial● In Stock | $44.99BEST | $8.998 | ||
![]() |
Dihexa 10mg | vial | 1 vial● In Stock | $49.99VALUE | $4.999 |
Nootropics
9-Methyl-β-carboline (9-MBC) is a synthetic β-carboline alkaloid that has gained significant interest in the nootropic community for its reported ability to promote dopaminergic neuron growth, increase dopamine synthesis enzymes, and provide neuroprotective effects against neurotoxins.
Nootropics
Alpha-GPC (L-alpha glycerylphosphorylcholine) is a choline-containing phospholipid naturally present in the brain and found in small amounts in dairy and meat.
Nootropics
Bromantane (Ladasten) is an atypical psychostimulant and anxiolytic developed in Russia, approved there for asthenia.
Nootropics
CDP-Choline (cytidine diphosphocholine, citicoline) is a naturally occurring nucleotide found in every cell in the body, and one of the most evidence-backed nootropics available.
Nootropics
Lion's Mane (Hericium erinaceus) is a medicinal mushroom with a growing body of clinical evidence for cognitive enhancement, neurogenesis, and nerve repair.
Nootropics
Noopept (GVS-111) is a synthetic dipeptide nootropic developed in Russia and approved there as a cognitive enhancer.
1 PubMed studies
Data Completeness
100%Research Credibility
Limited research available
Half-Life
Unknown in humans (animal studies suggest rapid metabolism with sustained CNS effects)
Molecular Weight
450.58 g/mol
Administration
Oral, Intranasal, Subcutaneous
CAS Number
1191170-93-0
Trial Phase
Preclinical
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. It is considered one of the most potent cognitive enhancers ever tested in animal models — reportedly 7 orders of magnitude more potent than BDNF at improving cognitive performance in rodent Alzheimer's models. Exclusively used by the research and biohacking community with no human clinical trial data available.
Dihexa is available in vial form.
Prices start at $44.99 across 2 verified vendors.
Compare prices, payment methods, shipping, and COA scores across 2 vendors.
Nootropics
9-Methyl-β-carboline (9-MBC) is a synthetic β-carboline alkaloid that has gained significant interest in the nootropic community for its reported ability to promote dopaminergic neuron growth, increase dopamine synthesis enzymes, and provide neuroprotective effects against neurotoxins.
Nootropics
Alpha-GPC (L-alpha glycerylphosphorylcholine) is a choline-containing phospholipid naturally present in the brain and found in small amounts in dairy and meat.
Nootropics
Bromantane (Ladasten) is an atypical psychostimulant and anxiolytic developed in Russia, approved there for asthenia.
Nootropics
CDP-Choline (cytidine diphosphocholine, citicoline) is a naturally occurring nucleotide found in every cell in the body, and one of the most evidence-backed nootropics available.
Nootropics
Lion's Mane (Hericium erinaceus) is a medicinal mushroom with a growing body of clinical evidence for cognitive enhancement, neurogenesis, and nerve repair.
Nootropics
Noopept (GVS-111) is a synthetic dipeptide nootropic developed in Russia and approved there as a cognitive enhancer.